{"id":7528,"date":"2024-08-06T23:45:38","date_gmt":"2024-08-06T21:45:38","guid":{"rendered":"https:\/\/everydaybetter.nl\/?p=7528"},"modified":"2026-03-24T16:10:15","modified_gmt":"2026-03-24T15:10:15","slug":"breakthrough-in-hiv-treatment-the-promising-role-of-nmn","status":"publish","type":"post","link":"https:\/\/everydaybetter.nl\/en\/breakthrough-in-hiv-treatment-the-promising-role-of-nmn\/","title":{"rendered":"Breakthrough in HIV treatment: The promising role of NMN"},"content":{"rendered":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text]\n<div class=\"flex-shrink-0 flex flex-col relative items-end\">\n<div class=\"pt-0\">\n<div class=\"gizmo-bot-avatar flex h-8 w-8 items-center justify-center overflow-hidden rounded-full\">\n<div class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\">\n<p>The Human Immunodeficiency Virus (HIV) remains a significant challenge in the medical world, despite advances in treatment with combination antiretroviral therapy (cART). Approximately 30% of patients using cART do not sufficiently restore their CD4+ T-cell counts, leading to an increased risk of AIDS and other infections. However, recent research points to a promising new treatment: Nicotinamide Mononucleotide (NMN). This article discusses the potential benefits of NMN in HIV treatment and how it can contribute to improved immune response and restoration of CD4+ T-cells.   <\/p>\n<h3>What is NMN?<\/h3>\n<p>Nicotinamide Mononucleotide (NMN) is a direct precursor to Nicotinamide Adenine Dinucleotide (NAD+), a crucial co-enzyme involved in various cellular processes, such as DNA repair and energy metabolism. As we age, NAD+ levels in the body decrease, which can contribute to various age-related conditions and reduced immune functions\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>Medicine.net<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>eMedNews<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b. <\/p>\n<h3>The Role of CD4+ T cells in HIV<\/h3>\n<p>CD4+ T-cells, also known as T-helper cells, play an essential role in the immune system by coordinating the immune response against infections. HIV specifically targets these cells, leading to a weakened immune response and increased susceptibility to opportunistic infections\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>Medicine.net<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b. <\/p>\n<h3>Research on NMN and HIV<\/h3>\n<p>Recent research published in EBioMedicine has shown that NMN has a positive impact on immune activation in CD4+ T-cells in HIV-infected individuals. In vitro studies have shown that NMN treatment increases intracellular NAD+ levels and inhibits HIV-1 replication, resulting in a reduction of viral p24 protein production in infected cells without significant cytotoxicity\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>Medicine.net<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>eMedNews<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b. <\/p>\n<h3>Mechanisms of NMN<\/h3>\n<p>NMN appears to suppress the expression of late T-cell activation markers, molecules that are present on the surface of activated T-cells. This helps to reduce the activation of CD4+ T-cells, making these cells less susceptible to HIV infection. In addition, NMN appears to influence the proliferation of infected CD4+ T-cells by regulating the expression of CD25 receptors and reducing the proliferation of primary p24+ CD4+ T-cells\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>eMedNews<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>Classifieds4W Health<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b.  <\/p>\n<h3>Survey Results<\/h3>\n<p>In experiments with both primary CD4+ T-cells and in humanized mouse models, NMN treatment showed significantly improved CD4+ T-cell reconstitution compared to cART alone. This combination also led to lower frequencies of apoptotic, hyperactivated, and CD25+ activated CD4+ T-cells, indicating a suppressive effect on T-cell hyperactivation and HIV-1 replication. These findings suggest that NMN, in combination with cART, may improve the effectiveness of HIV-1 therapy by modulating CD4+ T-cell activation and proliferation\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>eMedNews<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"><span class=\"text-token-text-secondary\"> (<\/span>Classifieds4W Health<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b.  <\/p>\n<h3>Conclusion and Future Directions.<\/h3>\n<p>The promising results of this research offer hope for a new treatment strategy for HIV\/AIDS. NMN\u2019s ability to reduce CD4+ T-cell activation and suppress the expression of activation markers offers an intriguing possibility for the development of new therapies. However, further large-scale clinical trials are needed to definitively establish the safety and effectiveness of NMN in human populations. If these findings are validated, NMN could become a powerful tool in the fight against HIV\/AIDS, which could significantly improve the quality of life for millions of people worldwide.   <span class=\"\" data-state=\"closed\"> <span class=\"text-token-text-secondary\"> (<\/span>Medicine.net<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"> <span class=\"text-token-text-secondary\"> (<\/span>Ground News<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"> <span class=\"text-token-text-secondary\"> (<\/span>eMedNews<span class=\"text-token-text-secondary\">)<\/span><\/span>\u200b\u200b<span class=\"\" data-state=\"closed\"> <span class=\"text-token-text-secondary\"> (<\/span>Classifieds4W Health<span class=\"text-token-text-secondary\">)<\/span><\/span>.<\/p>\n<h3>References<\/h3>\n<ul>\n<li>Wang, S., et al. (2023).  Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice.  The Lancet.<\/li>\n<\/ul>\n<p>By building on this promising research, scientists and medical professionals can continue to strive for more effective treatments and ultimately a cure for HIV\/AIDS.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][image_with_animation image_url=&#8221;7531&#8243; image_size=&#8221;full&#8221; animation_type=&#8221;entrance&#8221; animation=&#8221;None&#8221; animation_movement_type=&#8221;transform_y&#8221; hover_animation=&#8221;none&#8221; alignment=&#8221;&#8221; border_radius=&#8221;none&#8221; box_shadow=&#8221;none&#8221; image_loading=&#8221;default&#8221; max_width=&#8221;100%&#8221; max_width_mobile=&#8221;default&#8221;][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":7530,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[523,472,520,473],"tags":[525,475,474],"class_list":{"0":"post-7528","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-en","8":"category-nicotinamide-mononucleotide-en","9":"category-nmn-en","10":"category-science","11":"tag-hiv-en","12":"tag-nmn-en","13":"tag-science"},"_links":{"self":[{"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/posts\/7528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/comments?post=7528"}],"version-history":[{"count":0,"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/posts\/7528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/media\/7530"}],"wp:attachment":[{"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/media?parent=7528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/categories?post=7528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/everydaybetter.nl\/en\/wp-json\/wp\/v2\/tags?post=7528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}